Literature DB >> 1594649

Reduction of frequency of seizures by carbamazepine during cobalt experimental epilepsy in the rat.

C R Craig1, B K Colasanti.   

Abstract

Adult female Sprague-Dawley rats rendered epileptic by bilateral cerebral implantation of cobalt wire were simultaneously prepared with permanent cortical and temporalis muscle electrodes for continuous recording of electroencephalogram and electromyogram activities. Carbamazepine (50 or 100 mg/kg) was administered intraperitoneally twice daily days 8-12 after cobalt implantation. The high dose of carbamazepine was effective in decreasing seizure incidence each day of its administration, but the lower dose was effective in decreasing seizure incidence only for 6 h following its administration on days 8 and 9. These results provide additional evidence that cobalt epilepsy in the rat is a valid model for the study of seizure disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1594649     DOI: 10.1016/0091-3057(92)90232-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  1 in total

1.  Locally applied valproate enhances survival in rats after neocortical treatment with tetanus toxin and cobalt chloride.

Authors:  Dirk-Matthias Altenmüller; Jonas M Hebel; Michael P Rassner; Silvanie Volz; Thomas M Freiman; Thomas J Feuerstein; Josef Zentner
Journal:  Biomed Res Int       Date:  2013-09-14       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.